Clinical Outcomes of Adult Patients Hospitalized with COVID-19 after Vaccination.

COVID-19 SARS-COV-2 breakthrough infections vaccination

Journal

Tropical medicine and infectious disease
ISSN: 2414-6366
Titre abrégé: Trop Med Infect Dis
Pays: Switzerland
ID NLM: 101709042

Informations de publication

Date de publication:
26 Sep 2021
Historique:
received: 15 08 2021
revised: 20 09 2021
accepted: 24 09 2021
entrez: 26 10 2021
pubmed: 27 10 2021
medline: 27 10 2021
Statut: epublish

Résumé

Vaccination remains the most effective way to prevent COVID-19. The aim of the present study was to assess the incidence of COVID-19 hospitalizations after vaccination, as well as the effect of prior vaccination on hospitalization outcomes among patients with COVID-19. We analyzed and compared all consecutive patients, with or without prior vaccination, who were admitted to our hospital network due to COVID-19 from January to April 2021. Our primary outcome was to identify and describe cases of COVID-19 hospitalized after vaccination. We also utilized a multivariate logistic regression model to investigate the association of previous vaccination with hospitalization outcomes. We identified 915 consecutive patients hospitalized due to COVID-19 with 91/915 (10%) previously vaccinated with at least one dose of a COVID-19 vaccine. Utilizing our multivariate logistic regression model, we found that prior vaccination, regardless of the number of doses or days since vaccination, was associated with decreased mortality (aOR 0.44, 95% CI: 0.20-0.98) when compared to unvaccinated individuals. Our study showed that COVID-19 related hospitalization after vaccination may occur to a small percentage of patients, mainly those who are partially vaccinated. However, our findings underline that prior vaccination, even when partial, is associated with a decreased risk of death. Ongoing vaccination efforts should remain an absolute priority.

Identifiants

pubmed: 34698280
pii: tropicalmed6040175
doi: 10.3390/tropicalmed6040175
pmc: PMC8544707
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Nature. 2021 Jun;594(7862):164-167
pubmed: 34089016
N Engl J Med. 2021 Jun 10;384(23):2212-2218
pubmed: 33882219
N Engl J Med. 2021 Apr 15;384(15):1412-1423
pubmed: 33626250
N Engl J Med. 2021 Sep 23;385(13):1244-1246
pubmed: 34379917
Transpl Infect Dis. 2021 Aug;23(4):e13654
pubmed: 34051026
MMWR Morb Mortal Wkly Rep. 2021 May 28;70(21):792-793
pubmed: 34043615
N Engl J Med. 2021 Feb 4;384(5):403-416
pubmed: 33378609
N Engl J Med. 2021 Oct 14;385(16):1474-1484
pubmed: 34320281
Lancet. 2021 Mar 6;397(10277):875-877
pubmed: 33610193
J Am Geriatr Soc. 2021 Jun;69(6):1441-1447
pubmed: 33768521
N Engl J Med. 2020 Dec 31;383(27):2603-2615
pubmed: 33301246

Auteurs

Markos Kalligeros (M)

Infectious Diseases Division, Warren Alpert Medical School of Brown University, Providence, RI 02903, USA.
Department of Medicine, Warren Alpert Medical School of Brown University, Providence, RI 02903, USA.

Fadi Shehadeh (F)

Infectious Diseases Division, Warren Alpert Medical School of Brown University, Providence, RI 02903, USA.

Evangelia K Mylona (EK)

Infectious Diseases Division, Warren Alpert Medical School of Brown University, Providence, RI 02903, USA.

Matthew Kaczynski (M)

Infectious Diseases Division, Warren Alpert Medical School of Brown University, Providence, RI 02903, USA.

Saisanjana Kalagara (S)

Infectious Diseases Division, Warren Alpert Medical School of Brown University, Providence, RI 02903, USA.

Eleftheria Atalla (E)

Infectious Diseases Division, Warren Alpert Medical School of Brown University, Providence, RI 02903, USA.

Maria Tsikala Vafea (M)

Infectious Diseases Division, Warren Alpert Medical School of Brown University, Providence, RI 02903, USA.

Eleftherios Mylonakis (E)

Infectious Diseases Division, Warren Alpert Medical School of Brown University, Providence, RI 02903, USA.

Classifications MeSH